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IN HIPPOCAMPAL CA1 SUBFIELD AFTER
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ABSTRACT - Objective: To further characterize the capacity of lovastatin to prevent hippocampal neuronal loss
after pilocarpine-induced status epilepticus (SE) Method: Adult male Wistar rats were divided into four gro u p s :
(A) control rats, received neither pilocarpine nor lovastatin (n=5); (B) control rats, received just lovastatin (n=5);
(C) rats that received just pilocarpine (n=5); (D) rats that received pilocarpine and lovastatin (n=5). After pilo-
carpine injection (350mg/kg, i.p.), only rats that displayed continuous, convulsive seizure activity were included
in our study. Seizure activity was monitored behaviorally and terminated with an injection of diazepam (10 mg/kg,
i.p.) after 4 h of convulsive SE. The rats treated with lovastatin received two doses of 20mg/kg via an oesophag-
ic probe immediately and 24 hours after SE induction. Seven days after pilocarpine-induced SE, all the animals
w e reperfused and their brains were processed for histological analysis through Nissl method. Results: The cell
counts in the Nissl-stained sections perf o rmed within the hippocampal formation showed a significant cell loss
in rats that received pilocarpine and presented SE (CA1= 26.8 ± 13.67; CA3= 38.1 ± 7.2; hilus= 43.8 ± 3.95) when
c o m p a red with control group animals (Group A: CA1= 53.2 ± 9.63; CA3= 63.5 ± 13.35; hilus= 59.08 ± 10.24; Gro u p
B: CA1= 74.3 ± 8.16; CA3= 70.1 ± 3.83; hilus= 70.6 ± 5.10). The average neuronal cell number of CA1 subfield of
rats that present SE and received lovastatin (44.4 ± 17.88) was statically significant increased when compare d
with animals that just presented SE. Conclusion: Lovastatin exert a neuro p rotective role in the attenuation of
brain damage after SE.
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Lovastatina reduz a lesão celular na região CA1 do hipocampo após o status epilepticus i n d u z i d o
pela pilocarpina: resultados preliminares
RESUMO - Objetivo: Capacidade da lovastatina em prevenir a perda de neurônios hipocampais após o status
epilepticus (SE) induzido pela pilocarpina. Método: Ratos adultos Wistar foram divididos em 4 grupos: (A) ratos
c o n t roles que não receberam pilocarpina nem lovastatina (n=5); (B) ratos controles que receberam somente lovas-
tatina (n=5); (C) ratos que receberam somente pilocarpina (n=5); (D) ratos que receberam pilocarpina e lovastati-
na (n=5). Após a administração de pilocarpina (350mg/kg, i.p.), somente ratos que evoluíram para o status epilep-
ticus foram incluídos em nosso estudo. A atividade epiléptica foi interrompida com uma injeção de diazepam
(10 mg/kg, i.p.) após 4h do início do SE. Os ratos tratados com lovastatina receberam duas doses de 20mg/kg via
esofágica, imediatamente e 24 h após a indução do SE. Sete dias após o SE induzido pela pilocarpina, todos os
animais foram perfundidos e seus cére b ros processados para análise histológica através do método de Nissl.
Resultados: A contagem celular da formação hipocampal mostrou uma significante perda celular nos animais
que receberam pilocarpina e apresentaram SE (CA1= 26,8 ± 13,67; CA3= 38,1 ± 7,2; hilus= 43,8 ± 3,95) quando
comparados com animais pertencentes ao grupo controle (Grupo A: CA1= 53,2 ± 9,63; CA3= 63,5 ± 13,35; hilus=
59,08 ± 10,24; Grupo B: CA1= 74,3 ± 8,16; CA3= 70,1 ± 3,83; hilus= 70,6 ± 5,10). O número de células neuro n a i s
na região CA1 do hipocampo de ratos que apresentaram SE e receberam lovastatina (44,4 ± 17,88) foi estatisti-
camente maior quando comparado com animais que somente apresentaram SE. Conclusão: A lovastatina exerc e
papel neuro p rotetor na atenuação do dano cerebral após o SE.
PALAVRAS-CHAVE: epilepsia, pilocarpina, lovastatina, hipocampo.
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Status epilepticus (SE), a neurological emerg e n-
cy characterized by abnormally prolonged seizure s ,
remains an important clinical pro b l e m1. Animal m o d-
els of SE have been used to produce chronic epilep-
s y, thus suggesting that SE itself is epileptogenic2.
The systemic administration of a potent agonist p i l o-
carpine to rats leads to a pattern of repetitive lim-
bic seizures and SE, which can last for up 12 h o u r s3 , 4.
Morphological analysis of hippocampal form a t i o n
after pilocarpine-induced SE shows an extensive
loss of neurons within the hilar area of the denta-
te gyru s4 , 5, as well a loss of selective populations of
interneurons in areas CA1 and CA3 and in the hi-
l u s4. Furt h e rm o re, SE-associated cell loss is a critical
step that activates a cascade of events leading to
mossy fiber sprouting, de novo re c u rrent excitat i o n
of granule cells, culminating in spontaneous re-
current seizures (SRSs)4-6.
Lovastatin, a fungal antibiotic used in hyperc h o-
l e s t e rolemia treatment, is a competitive inhibitor
of HMG-CoA (3-hydro x y - 3 - m e t h y l g l u t a ryl coenzime
A reductase), the major re g u l a t o ryenzyme of d e
n o v o c h o l e s t e rol synthesis7. Recent data reveal that
statins reduce vascular inflammatory re s p o n s e s8,
p romote angiogenesis9, modulate cytokine pro d u c-
t i o n1 0 and decrease oxidative stre s s1 1. Furt h e rm o re ,
recent studies have shown that statins reduces the
extent of brain damage after ischemic insult1 2.
Based on this, the purpose of our study was to
f u rther characterize the capacity of lovastatin to
prevent hippocampal neuronal loss after pilocar-
pine-induced status epilepticus.
METHOD
Adult male Wistar rats (n=20), weighting 200-250g
w e re housed under standard controlled conditions (7:00
AM/7:00 P.M. light/dark cycle; 20-22oC; 45-55% humidi-
ty) with food and water ad libitum w e re used in our stu-
d y. The pro c e d u res involving the animals and their care
at the Neuroscience Laboratory at University of Mogi
das Cruzes respected the Institution’s guidelines, which
comply with national and international rules and polic i e s .
Rats were divided randomly into four groups: (A) cont ro l
rats, received neither pilocarpine nor lovastatin (n=5);
(B) control rats, received just lovastatin (n=5); (C) rats
that received just pilocarpine (n=5); (D) rats that re c e i v e d
pilocarpine and lovastatin (n=5).
SE were induced according to the pro c e d u re des-
cribed pre v i o u s l y4. In brief, 30 minutes after methylsco-
polamine injection (1mg/kg, s.c - used to reduce periph-
eral effects of pilocarpine), pilocarpine (350mg/kg, i.p.)
was administered to rats. Only rats that displayed conti-
nuous, convulsive seizure activity after pilocarpine tre a t-
ment were included in these studies. Seizure activity w a s
m o n i t o red behaviorally and terminated with an i.p. i n-
jection of diazepam (10 mg/kg; Roche, Brazil) after 4 h of
convulsive SE. Lovastatin was provided by Millenium P h a r-
macy (São Paulo, Brazil) and was diluted using sterile s a-
line 0,9%. The rats treated with lovastatin received two
doses of 20mg/kg via an oesophagic probe immediatel y
and 24 hours after SE induction.
Seven days after pilocarpine-induced SE, the animals
w e re perfused and the brains were processed for histo-
logical analysis. Sections cut 20 µm thick were stained
a c c o rding to Nissl method. Cell counts in the Nissl-stained
sections, were perf o rmed within the hippocampal pyra-
midal cell layer and the dentate hilus, as previously re-
p o rted by Mouritzen-Dam1 3. For each animal, both the
right and left hemispheres of three diff e rent sections
w e re counted to provide a total of five individuals valu-
es per animal. Only cells with evident nucleus and nucle-
olus were included in the counts. The mean value observ e d
in control rats was considered 100% of normal cell popu-
lation. Statistical analysis was perf o rmed by one-way
analysis of variance (ANOVA), followed by post-hoc
Dunnett´s test; p values of p<0.05 were considered stati-
cally significant. 
RESULTS
Pilocarpine treatment induced the following
behavioral changes: akinesia, facial automatisms,
and limbic seizures consisting of forelimb clonus
with rearing, salivation, and masticatory jaw move-
ments and falling. This type of behavior built up
p ro g ressively into motor limbic seizures that re-
c u rred repeatedly and rapidly and developed into
SE. After SE, animals were comatose or unre s p o n-
sive to their environment and akinetic; behavior
re t u rned toward normal over a 3 to 5-day period.
We next analyzed the qualitative morphological
changes in the hippocampus associated with lovas-
tatin treatment and SE. In the control animals (Fig
1A, 1B), the Nissl staining of hippocampal form a t i o n
and dentate gyrus showed integrity of all cells lay-
ers. In contrast, animals that received just pilocarpine
and presented SE (Fig 1C) we observed a significant
cell loss in hippocampal subfields CA1, CA3 and hilus
of dentate gyrus. Interesting, the structural analy-
sis of the brains from animals that presented SE and
received lovastatin (Fig 1D) was similar when com-
p a red with animals in the control gro u p .
F rom a quantitative point of view, Fig 2 shows
cell counts in the Nissl-stained sections perf o rm e d
within the hippocampal pyramidal cell layer (CA1
and CA3) and the dentate hilus. A significant cell
loss was observed in rats that received pilocarpine
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Fig 2. Neuronal cell count. Data re p re s e n t
average neuronal cell counts in contro l
rats, rats that received just pilocarpina and
rats that received pilocarpine and lovas -
tatin. Data were analyzed by ANOVA, fol -
lowed by post hoc Dunnett´s test. Note the
reduced cell loss in CA1 subfield of rats
that received pilocarpine and lovastatin
when compared with rats that just re c e i v e d
pilocarpina. Data expressed as mean ± S.E.
*p<0.05.
Fig 1. Nissl staining of hipocampal formation. Photomicrograph of hipocampal formation showing: (A)
c o n t rol rats, received neither pilocarpine nor lovastatin; (B) control rats, received just lovastatin; (C) rats
that received just pilocarpine; (D) rats that received pilocarpine and lovastatin. Scale bar: 600 µm
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and presented SE (CA1= 26.8 ± 13.67; CA3= 38.1 ±
7.2; hilus= 43.8 ± 3.95) when compared with con-
t rol group animals (Group A: CA1= 53.2 ± 9.63;
CA3= 63.5 ± 13.35; hilus= 59.08 ± 10.24; Group B:
CA1= 74.3 ± 8.16; CA3= 70.1 ± 3.83; hilus= 70.6 ±
5.10). The average neuronal cell number of CA1
subfield of rats that present SE and received lovas-
tatin (44.4 ± 17.88) was statistically significant in-
c reased when compared with animals that just pre-
sented SE. It is therefore of interest that the cells
in CA3 subfield and hilus of rats that present SE
and received lovastatin (CA3= 50.14 ± 15.33; hilus=
52.20 ± 18.71) tended to be relatively protect when
c o m p a redwith animals that just received pilocar-
pine and presented SE.
DISCUSSION
This study evaluated the effects of lovastatin
administration in rats after pilocarpine-induced S E .
We demonstrated that lovastatin treatment was
able to prevent hippocampal neuronal loss in CA1
subfield after an epileptic insult. In these lines, our
results are in agreement with a recent study that re-
p o rted an effective neuro p rotective action of sta-
tins after an acute brain injury14.
Reactive oxygen species (ROS) are a part of nor-
mal human metabolism; however, when pro d u c e d
in excess, ROS can cause tissue injury including lipid
p e roxidation, DNA damage and enzyme inactiva-
t i o n8. ROS is a common denominator among acute
n e u rological conditions8 , 1 5, including epilepsy1 6 , 1 7. In
the pilocarpine model, there is a involvement of exci-
totoxic neuronal injury1 8 and ROS production has
been considered to be a part of mechanisms involved
with glutamatergic excitotoxicity in vitro1 5 and in
v i v o1 6 , 1 7 , 1 9. More o v e r, it was demonstrated that lovas-
tatin treatment inhibits free radical injury2 0. Thus,
this antioxidant effect of statins could explain the
n e u ro p rotective pro p e rties found in our study.
T h e re is one classical argument supporting a
possible role of nitric oxide (NO) in convulsive phe-
nomena: excitatory amino acids, such as N-methyl-
D- aspartate (NMDA) and kainate, are known to
be potent convulsants2 1, and the activation of N M D A
receptors is accompanied by the formation of NO2 2.
In fact, the role of NO in epileptogenesis has been
examined in a number of studies, suggesting to be
a proconvulsive endogenous substance2 3 , 2 4. Fur-
t h e rm o re, some studies have revealed that statins
inhibit the production of NO in brain pare n c h ym a1 0,
indicating that statins, secondarily, may play the
role of an anticonvulsant substance, does not pro-
moting glutamate-mediated neuro t o x i c i t y. Other
possibility is that the inhibition of brain endothe-
lial nitric oxide synthase (eNOS) leads to incre a s e d
blood pre s s u re2 5, which, in turn, may affect the ex-
citability of central nervous system2 6; however, it
was demonstrated that statins are able to upre g u-
late eNOS2 7, may be pivotal in enhance cerebral a rt e-
rial vasodilator responses, decreasing with this,
the firing threshold.
F i n a l l y, anti-inflammatory effects of statins
could also contribute to neuro p rotection after pilo-
carpine-induced SE observed in our study. The pa-
thological alterations that occur in the hippocam-
pus following prolonged seizures begin within
hours and cause changes that last throughout life.
M o re o v e r, several studies has implicated a number
of cytokines in seizure - related hippocampal pathol-
o g y2 8 , 2 9. Intere s t i n g l y, Pahan and colleagues1 0 h a v e
been shown that lovastatin reduces the induction
of inflammatory mediators. Taken together, lovas-
tatin treatment may provide an important appro-
ach to suppression of the inflammatory re s p o n s-
es after SE induced by pilocarpine. 
Based on these facts, our pre l i m i n a ryresults s u p-
p o rtprevious evidence that statins reduces neuro-
nal death after an acute brain insult. Future studi-
es are needed to gain a better understanding of t h e-
se and other possible mechanisms of lovastatin du-
ring epileptogenesis
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